BRCA1 and non-small cell lung carcinoma: Combination experiments employing fascaplysin and AZD7762 showed synergistic effects with CI values ranging from 0.35 – 1.13 (mean value 0.54 ± 0.21), except of the BH419 BRCA1-mutated NSCLC cell line.